Effie Rahman, MD
Ophthalmology · Bellaire, TXNPI 1154777969
Payments from drug & device makers
Across 461 payments — averaging $1204.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$534K
- Regeneron$5K
- Ocular Therapeutix, Inc.$4K
- Eyepoint US, Inc.$3K
- Alimera Sciences, Inc.$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
- plus $6K from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 282 | $534,438 |
| Regeneron | 17 | $4,525 |
| Ocular Therapeutix, Inc. | 4 | $3,977 |
| Eyepoint US, Inc. | 6 | $2,971 |
| Alimera Sciences, Inc. | 10 | $1,757 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $1,718 |
| Regeneron Healthcare Solutions, Inc. | 41 | $1,692 |
| Apellis Pharmaceuticals, Inc. | 27 | $867 |
| Alcon | 5 | $602 |
| Astellas Pharma US Inc | 11 | $517 |
| Genentech USA, Inc. | 13 | $478 |
| Biogen | 7 | $391 |
| Genentech, Inc. | 4 | $387 |
| Samsara Vision | 1 | $279 |
| Bausch & Lomb Americas Inc. | 5 | $231 |
| Oculus Surgical Inc. | 2 | $157 |
| AbbVie | 5 | $115 |
| Astellas Pharma Global Development | 1 | $100 |
| Boehringer Ingelheim | 1 | $95 |
| Mallinckrodt Hospital Products Inc. | 1 | $72 |
| ANI Pharmaceuticals, Inc. | 3 | $66 |
| Coherus Oncology, Inc. | 1 | $17 |
How this compares
$555,451 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Bellaire
- Charles WykoffBellaire$73.4M
- Hasenin Al-KhersanBellaire$1.9M
- Otis WaltonBellaire$493K
- Kelly LarkinBellaire$486K
- David BrownHouston$51.7M
- Sunil PatelAbilene$11.1M
- Chirag JhaveriAustin$9.4M
- Robert WongAustin$6.6M
- Fuad MakkoukAustin$6.6M
- Patrick WilliamsArlington$6.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.